Rapid development of drug-induced lupus nephritis in the absence of extrarenal disease in a patient receiving procainamide.
Department of Nephrology, London Health Sciences Centre, Ontario, Canada. kevin.mclaughlin@lhsc.on.ca
K
K
McLaughlin
B
B
Gholoum
C
C
Guiraudon
A
A
Jevnikar
N
N
Muirhead
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001706:Biopsy; D003937:Diagnosis, Differential; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000473:pathology*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000150:complications; D008181:Lupus Nephritis / Q000139:chemically induced*; D008297:Male; D011342:Procainamide / Q000009:adverse effects*
D000889:Anti-Arrhythmia Agents; D011342:Procainamide